Filter results

Pharmaceutical Reports

By Geography
By Sector
By Publication Type
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%
Showing
1-20 of 190
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

Pub date:24 Apr 2015

BMI View: Long-term growth prospects in Algeria's pharmaceutical and healthcare sector will continue to generate investment opportunities to foreign firms, including in the development of drug manufacturing capacity and technology transfer with joint partnerships ...
$1,295.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

Pub date:30 Apr 2015

BMI View: Angola's pharmaceutical market is held back by weak regulatory framework and lack of intellectual property legislation which create a challenging environment for i nnovative drugmakers. The fall in the price of oil ...
$1,295.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

Pub date:01 May 2015

BMI View: Argentina's pharmaceuticals and healthcare sector is expected to experience improved growth rates through the next decade, standing slightly behind growth pattern s in the other l arge markets in Latin America. Combined ...
$1,295.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

Pub date:27 Jul 2015

BMI View: The Australian pharmaceutical market is expected to continue on a moderate growth trajectory over our forecast period. This is mainly explained by rising chronic disease burden as well as government funding to list ...
$1,295.00
Read More
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

Pub date:05 May 2015

BMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. Nevertheless, our pharmaceutical and healthcare expenditure growth expectations remain resiliently subdued over ...
$1,295.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

Pub date:27 May 2015

BMI View: We believe Bahrain's pharmaceutical market outlook will continue its rapid growth over our forecast period. Although small, a growing and aging population and will drive long-term medicine demand in the country along ...
$1,295.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

Pub date:09 Jun 2015

BMI View: Bangladesh's pharmaceutical and healthcare sector growth will continue to stand on robust long-term fundamentals, including population growth, rising inc omes, urbanisation and economic expansion. Moreover, the country's efforts to increase drug ...
$1,295.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

Pub date:02 Jun 2015

BMI View: Collapsing external trade will have a highly damaging impact on living standards in Belarus, impacting incomes, employment and consumer sentiment, and we expect the pharmaceutical sector to be hurt by these factors. We ...
$1,295.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

Pub date:16 Jun 2015

BMI View: With structurally higher prices than many regional markets and quickly rising pharmaceutical consumption, Belgium will continue to present a high level of potential reward to drugmaker . Notably, a distinct lack of price transparency ...
$1,295.00
Read More
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

Pub date:29 May 2015

BMI View: Multinational drugmaker presence in Botswana will be limited to imports via leading distributors Medswana and Delta. Domestic manufacturing output will increase over the long-term and will be mainly focussed on generic anti-retrovirals given ...
$1,295.00
Read More
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

Pub date:29 May 2015

BMI View: With a focus on increasing foreign investment, an expansion of telehealth and a steadily growing burden of chronic diseases, Brazil will continue to offer commercial opportunities as the demand for medical provision as ...
$1,295.00
Read More
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

Pub date:18 May 2015

BMI View: Pharmaceutical manufacturers will face increased pricing pressures from the National Health Insurance Fund ( NHIF ) as we expect a wave of cost-containment measures to be adopted. The NHIF will leverage its purchasing power to ...
$1,295.00
Read More
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

Pub date:02 Jul 2015

BMI View: Despite improvements to the healthcare sector, high out of pocket expenditure means that access to healthcare will remain a challenging issue in Cambodia. Further investments in the sector will boost overall care quality ...
$1,295.00
Read More
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

Pub date:15 May 2015

BMI View : Headline Expenditure Projections Pharmaceuticals: XAF170.33bn (USD348mn) in 2014 to XAF187.60bn (USD315mn) in 2015; +10.1% in local currency terms and -9.6% in US dollar terms. Forecast revised downwards from last quarter . Healthcare: XAF802.48 ...
$1,295.00
Read More
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

Pub date:29 May 2015

BMI View: Canada will continue to support markedly above regional average rewards for drugmakers well into the forecast period. Rising consumption of high value pharmaceuticals and biologics stems from a mature population with above OECD ...
$1,295.00
Read More
Central America Pharmaceuticals & Healthcare Report

Central America Pharmaceuticals & Healthcare Report

Pub date:30 Jul 2015

BMI View: Growing demand for pharmaceuticals, compounded by underdeveloped manufacturing capabilities will ensure commercial opportunities for foreign investors within Central America over the long term. Multinational drugmakers and medical suppliers will also continue to benefit ...
$1,295.00
Read More
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

Pub date:02 Jul 2015

BMI View : Highlighted by the passing of the 'Ricarte Soto Law' , Chile will maintain its attractiveness as a growth market for drugmakers as the government displays a firm commitment to expanding public access to health ...
$1,295.00
Read More
China Pharmaceuticals and Healthcare Report

China Pharmaceuticals and Healthcare Report

Pub date:01 Jun 2015

BMI View: Multinational pharmaceutical companies will continue to invest and grow their presence in China, despite the slowdown in the economy. Driving this outlook is the outperformance of the pharmaceutical sector as authorities continue to ...
$1,295.00
Read More
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

Pub date:08 May 2015

BMI View: A growing burden of chronic diseases, along with the Colombian government's push toward improving its national healthcare system will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. Despite ...
$1,295.00
Read More
Cote d'Ivoire Pharmaceuticals & Healthcare Report

Cote d'Ivoire Pharmaceuticals & Healthcare Report

Pub date:31 Jul 2015

BMI View: Pharmaceutical expenditure in Cote d'Ivoire will be driven by both strong private consumption growth, in addition to public spending, through the introduction of the universal health insurance scheme. Growth will be driven ...
$1,295.00
Read More
Showing
1-20 of 190